The effects of ACE inhibition on progression of atherosclerosis

Area of Science:

• Cardiovascular Pharmacology
• Vascular Biology

Background:

• Angiotensin-converting enzyme (ACE) inhibitors are established treatments for hypertension, heart failure, and ventricular dysfunction.
• Their cardiac and vascular protective effects are recognized, but underlying mechanisms require further elucidation.
• Distinguishing between effects on endothelial function/atherosclerosis and vascular injury/hypertrophy is crucial.

Purpose of the Study:

• To explore the mechanisms of ACE inhibitors beyond blood pressure reduction.
• To investigate their potential role in preventing atherosclerosis and vascular remodeling.
• To provide rationale for clinical trials assessing ACE inhibitors in atherosclerotic disease.

Main Methods:

• Review of experimental animal studies on ACE inhibition and vascular injury/atherosclerosis.
• Analysis of laboratory findings on endothelial function and ACE inhibition.
• Examination of proposed mechanisms, including inhibition of angiotensin II and kinin accumulation.

Main Results:

• Animal studies suggest ACE inhibition can prevent myointimal proliferation after vascular injury.
• Laboratory studies show ACE inhibitors protect endothelial vasomotor function.
• Evidence indicates ACE inhibition can prevent atherosclerosis in animal models.

Conclusions:

• ACE inhibitors demonstrate potential in maintaining endothelial function and inhibiting atherosclerosis.
• Mechanisms may involve inhibiting angiotensin II and accumulating kinins, independent of blood pressure reduction.
• Clinical studies are warranted to confirm if ACE inhibitors can reduce atherosclerotic disease and broaden their therapeutic scope.